New price cap on 137 non‑scheduled cancer medicines announced
The Ministry of Chemicals and Fertilizers, through the NPPA, has imposed a price ceiling on 137 anticancer drugs that are not covered under the scheduled‑drugs list. The Trade Margin Regulation limits the trade margin to 30 percent of the MRP, a step expected to bring down retail prices by up to 70 percent.
The revised pricing framework becomes operational on 9 November 2026. It mirrors a 2019 trial in which limiting margins for 42 oncology drugs forced manufacturers to cut prices dramatically, delivering up to a 90 percent reduction for hundreds of brand variants.